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COVID-19, since emerged in Wuhan, China, has been a major concern due to its high 
infection rate, leaving more than one million infected people around the world. Huge number of 
studies tried to reveal the structure of the SARS-CoV-2 compared to the SARS-CoV-1, in order to 
suppress this high infection rate. Some of these studies showed that the mutations in the SARS-
CoV-1 Spike protein might be responsible for its higher affinity to the ACE2 human cell receptor. 
In this work, we used molecular dynamics simulations and Monte Carlo sampling to compare the 
binding affinities of the spike proteins of SARS-CoV and SARS-CoV-2 to the ACE2. We found 
that the SARS-CoV-2 binds to ACE2 stronger than SARS-CoV by 7 kcal/mol, due to enhanced 
electrostatic interactions. The major contributions to the electrostatic binding energies are resulting 
from the salt-bridges formed between R426 and ACE2-E329 in case of SARS-CoV and K417 and 
ACE2-D30 for SARS-CoV2.  In addition, there is no significant contribution from a single mutant 
to the binding energies. However, these mutations induce sophisticated structural changes that 
enhance the binding energies. Our results also indicate that the SARS-CoV-2 is unlikely a lab 
engineered virus. 
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A highly infectious strain of the SARS-
CoV known as SARS-CoV-2 emerged in 
Wuhan China and was first reported on the 31st 
of December 2019, according to the World 
Health Organization (WHO)1. This strain has 
already resulted in more than 1 million 
infections and over 60,000 deaths all over the 
world. Previous studies conducted on the first 
SARS-CoV strain showed that the most likely 
mechanisms by which the virus interacted with 
a cell, were mediated by the receptor binding 
domain (RBD) on the S protein, which binds 
the human angiotensin-converting enzyme 2 
(ACE2)2. 
  Similarly, SARS-CoV-2 was proposed 
to garner entry to the cells through the 
RBD.3،4،5 However, there are several mutations 
identified in the RBD, which include: 𝑉404 →𝐾417, 𝑅426 → 𝑁439, 𝑌442 → 𝐿455, 𝐿443 → 𝐹456, 𝐿460 → 𝐹473, 𝐿472 →𝐹486, 𝐿479 → 𝑄493, 𝐷480 → 𝑆456, 𝑌484 → 𝑄498, 𝑇487 → 𝑁501, according to 
the latest resolved structure using Cryo-
electron microscopy.5 Furthermore, another 
study using comparative genomics identified 
only 5 mutations and stated that RBD does not 
contain insertion or deletion.6 The 𝑉404 →𝐾417 mutation balances the 𝑅426 → 𝑁439 
since they include the addition and removal of 
positively charged amino acids respectively. 
However, the 𝐷480 → 𝑆456 mutation 
removes a negatively charged amino acid and 
is expected to make the electrostatic surface 
potential of SARS-CoV-2 more positive. 
In this work, we study the binding 
energies between the ACE2 receptor and the 
Spike protein of SARS-CoV and SARS-CoV-
2 viruses using Monte Carlo (MC) sampling 
and Molecular Dynamics (MD) simulations. 
To study the interactions between the 
SARS-CoV and the ACE2, the crystal 
structure 2AJF,1 which includes the receptor 
binding domain RBD is MD optimized using 
openMM software.9-14. Then, the optimized 
structure is inputted to MCCE (Multi 
Conformer Continuum Electrostatic)  
 
 
 
software16 to sample the protonation states of 
the amino acids using Monte Carlo. The 
electrostatic interactions between the different 
amino acids’ conformers are calculated by 
solving Possion Boltzmann equation using 
 
Figure 1. The electrostatic potential maps in 
kT/e of (a) the SARS-CoV, (b) SARS-CoV-
2 and C) the ACE2. 
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DELPHI.17 The generated conformers’ 
occupancies based on Boltzmann distributions 
are used to calculate the electrostatic and van 
der Waals interactions between the amino 
acids in the SARS-CoV and the ACE2. 
 However, to study the interactions between 
the SARS-CoV-2 and the ACE2, we 
constructed the following mutants (V404K, 
R426N, Y442L, L443F, F460Y, L472F, 
N479Q, D480S, Y484Q, T487N) based on the 
cryoEM structure PDB ID 6M17.7 The 
mutations were performed by replacing the 
sidechains in the native structures with the 
proper sidechains of the mutants using MCCE. 
Several confirmations of the sidechains were 
created to void van der Waals clashes. The 
sidechain conformers with the highest 
Boltzmann occupancies were then MD 
optimized. The MCCE was then used to 
calculate the binding energies based on the 
optimized structures. 
The electrostatic potential maps of 
SARS-CoV, SARS-CoV-2 and ACE2 were 
calculated using Adaptive Poisson-Boltzmann 
Solver (APBS)16 (Figure1. a, b, and c). The 
ACE2 exhibit a negative electrostatic potential 
at the RBD (Figure1. c), while both SARS-
CoV and SARS-CoV-2 show positive 
potentials. However, the potential observed for 
SARS-CoV-2 is more positive, which will 
result in a greater electrostatic attraction 
between ACE2 and SARS-CoV-2. This could 
be explained by the replacement of the 
negatively charged amino acid Asp by a 
neutral Ser (D480S). 
 
The optimized structure of SARS-CoV shows 
salt-bridges formed between SARS-CoV-
R426 and ACE2-E329, which dominates the 
electrostatic interactions with the ACE2. This 
salt-bridge is replaced by another salt-bridge 
formed between CoV-2-K404 and ACE2-D30 
in SARS-CoV-2 (Figure 2). However, the 
CoV2-K404/ACE2-D30 salt-bridge has more 
favorable electrostatic. attractions by 1.4 
Kcal/mol (Table 1).  The total electrostatic 
interactions between the SARS-CoV-2 and the 
ACE2   are stronger by 3 Kcal/mol than SARS-
CoV (Table S1). The contribution from the 
mutants themselves to the electrostatic binding 
energies is very small (Table S1).   
 
 
 
 
 
 
 
 
Figure 2. The MD optimized structure of 
SARS-CoV (top) and SARS-CoV-2 (bottom). 
The secondary structures of the spike protein 
and the ACE2 are shown in magenta and 
green respectively. Key residues are labeled 
and shown in cyan. The salt-bridges formed 
between R426 and E329 in SARS-CoV and 
K404 and D30 in SARS-CoV-2 are shown in 
black dots. 
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Furthermore, these mutants induce 
structural changes that increase the favorable 
van der Waals interactions in SARS-CoV-2. 
The maximum van der Waals attractions of -
1.6 Kcal/mol are observed between   CoV-
Y457 and ACE2-T27 for SARS-CoV, while 
for SARS-CoV-2 the maximum attraction is -
2.1 Kcal/mol observed between CoV2-D491 
and CoV2-K353 (Table 1). The total van der 
Waal’s contribution to the binding energy in 
case of SARS-CoV-2 is higher than SARS-
CoV by ~ 4Kcal/mol. In total, the electrostatic 
and van derWaalsattraction between the 
SARS-CoV-2 and the ACE2 is stronger by ~7 
Kcal/mol than the SAR-CoV. 
Several studies proposed that increased 
virulence of SARS-CoV-2 is due to the 
increased binding affinity to the ACE2 
receptor.3,6,7 Yan et al., proposed that mutation 𝑉404 → 𝐾417 may result in higher binding 
affinity due to the salt bridge between K417 
and D30, while the 𝑅426 → 𝑁439 mutation 
weaken the interaction with E329. However, 
our simulations show that the 𝑉404 → 𝐾417  
mutation increases the binding affinities by 
favorable electrostatic energies more than the 
energy loss induced by 𝑅426 → 𝑁439 
mutation. Additionally, mutation 	𝐿472 →
𝐹486 was proposed to weaken van der Waals 
contact with Met 82 of ACE2. On the contrary, 
the relaxed structure shows a van 
derWaalsattraction of -1.32 Kcal/mol.7 The 
structural changes induced by these mutations 
likely confer stability to CoV-2 as it binds to 
ACE2. This agrees with the study of Ortega et 
al.,8 where they found that two main residues 
(479 and 487) have been associated with 
human ACE2 recognition. They further found 
a higher number of residues in the CoV-2 
capping loops and attributed the more 
favorable binding affinity of -15.7 Kcal/mol as 
opposed to -14.1 Kcal/mol for CoV.8    
Based on our calculations, there is no 
significant contribution from a single mutant 
to the binding energies between the SARS and 
the ACE2. However, these mutations induce 
sophisticated structural changes that enhance 
the electrostatic and van der Waals binding 
energies (Table S1). These results might also 
support the idea that it is unlikely that the 
SARS-CoV-2 is lab engineered but rather a 
result of a biological evolution.18   
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Table 1. Total Electrostatic and van der Waals 
interactions between SARS-CoV, SARS-CoV-
2 and ACE2 
CoV->ACE2  CoV-2-> ACE2  
Electrostatics (Kcal/mol) 
R426 -> E329 -5.83 K404 -> D30 -7.22 
K390 -> D37  -1.01 Y491 -> E37 -1.28 
D393 -> K353 -0.95 K390 -> D37 -1.21 
Van der Waals (Kcal/mol) 
Y475 -> T27 -1.56 D491->K353 -2.10 
 I489 -> Q325 -1.34 Y475 -> K31 -1.50 
The major electrostatic contributions are 
observed for the R426/E329 salt-bridge for 
SARS-CoV and K404/D30 for SARS-CoV-2. 
Table S1 includes more information about the 
electrostatic and van derWaalsinteractions 
between SARS-CoV, SARS-CoV-2 and ACE2 
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Table S1. The electrostatic interactions between amino acids in the RBD for SARS-CoV and SARS-CoV-2. 
ARS-CoV-2 SARS-CoV 
Van der Waals 
Interactions 
Electrostatic 
Interactions 
Van der Waals 
Interactions 
Electrostatic 
Interactions 
CoV-
2 
ACE2 Force 
(Kcal/
mol) 
CoV-
2 
ACE
2 
Force 
(Kcal
/mol) 
CoV ACE2 Force 
(Kcal/
mol) 
CoV ACE2 Force 
(Kcal/
mol) 
Y 491 K 353 -2.1 K404 D 30 -7.22 Y475 T27 -1.56 R 426 E329 -5.83 
Y 475 K  31 -1.5        Y 491 E 37 -1.28 I 489 Q 325 -1.34 K 390 E 37 -1.01 
Q 484 K 353 -1.237      K 404 HIS 
34 
-1.24 LEU 
472 
M 82 -1.32 D 393 K 353 -0.95 
P 462 T 27 -1.222      K 390 E 37 -1.21 Y 442 K 31 -1.24 N 473 Y 83 -0.73 
Y 475 T 27 -1.207 N 473 Y 83 -0.99 Y 475 K 31 -1.2 R 426 D 329 -0.7 
F 472 M 82 -1.102 T 486 Y 41 -0.96 P 462 T 27 -1.12 D 480 K 37 -0.64 
Q 484 Y 41 -1.003      K 404 E 37 -0.67 
 
Y 484 Y 41 -1.021 K 390 D 353 -0.63 
N  
487 
K 353 -0.986  
 
K  390 D  30 -0.61 Y 491 K 353 -0.993 T 486 Y 83 -0.59 
N 473 Q 24 -0.973 D 393 R 393 -0.55 T 487 Y 41 -0.962 Q 492 E 329 -0.58 
I 489 Q 325 -0.964 D  393 K 353 -0.55 Y 491 K 353 -0.892 D 393 R 37 -0.54 
V 498 V 104 0.0        D 393 D 30 0.61 V 498 V 604 0.0 D 480 E 353 0.61 
V 498 V 581 0.0 
 
D  392 E  37 0.6 V 498 V 581 0.0 D 392 E 38 0.58 
V 498 V 574 0.0      K 404 R  393 0.52 V 498 V 574 0.0 D 393 D 37 0.5 
V  
498 
V  573 0.0      Q 484 K 353 0.5 V 498 V 573 0.0 D 393 D 393 0.48 
V 498 V 506 0.0 K 404 K 353 0.46 V 498 V 506 0.0 K 390 HIS 
353 
0.46 
N 473 Y 83 0.0005 D 393 E 37 0.73 V 498 V 491 0.0 R 426 R 38 0.42 
Y 491 E 37 0 .025 Q 484 D 355 0.74 T 486 Y 41 0.001  K 390 R 393 0.71 
N 473 Y 83 0.1515 Q 484 Y 41 0.78 T 486 Y 41 0.482 D 480 D 38 0.92 
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Y 491 E 37 0.324 K 390 R 393 0.81 T 486 Y 41 0.482 D 393 E 37 0.73 
K 404 D 30 0.637 K 390 K 353 1.02 R 426 E 329 3.446 K 390 K353 1.24 
  -11.14    -8.51    -7.242   -5.550 
